Skip to main content
Daniel Clayburgh, MD, Otolaryngology (ENT), Portland, OR

DanielRobertClayburghMD

Otolaryngology (ENT) Portland, OR

Physician

Dr. Clayburgh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clayburgh's full profile

Already have an account?

  • Office

    3181 Sw Sam Jackson Park Rd
    Portland, OR 97239
    Phone+1 503-494-8211

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Otolaryngology - Head and Neck Surgery, 2008 - 2013
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2008

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2014 - 2025
  • PA State Medical License
    PA State Medical License 2013 - 2014
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Sarcopenia with Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients with Localized Oropharyngeal Squamous Cell Carcinoma  
    Daniel Clayburgh, MD, JAMA Otolaryngology–Head & Neck Surgery
  • Comparison of Opioid Utilization Patterns After Major Head and Neck Procedures Between Hong Kong and the United States  
    Maisie Shindo, Peter Andersen, Mark Wax, Daniel Clayburgh, JAMA

Press Mentions

  • Analysis Suggests an ‘Urgent Need’ for Personalized Head and Neck Cancer Follow-Up
    Analysis Suggests an ‘Urgent Need’ for Personalized Head and Neck Cancer Follow-UpOctober 21st, 2022
  • Risk of Head and Neck Cancer in Patients with Prior Hematologic Malignant Tumors
    Risk of Head and Neck Cancer in Patients with Prior Hematologic Malignant TumorsMay 2nd, 2020

Professional Memberships